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Objective. This paper aims to assess 25(OH)D levels in Italian children and adolescents identifying risk factors for 25(OH)D
deficiency and to evaluate whether a normal 25(OH)D value can be restored in 25(OH)D-deficient patients.Methods.We evaluated
25(OH)D levels in 679 Italian children and adolescents (≤10, 11–20, 21–30, and >30 ng/mL were defined as severe deficiency,
deficiency, insufficiency, and sufficiency, resp.). Of these, 365 25(OH)D-deficient were followed up for 1 year; 205 were treated with
cholecalciferol (Arm A: 400 I.U.) and 160 by improving the environmental variables influencing 25(OH)D levels (Arm B). Results.
At cross-sectional evaluation, 11.3% showed sufficiency, 30.0% insufficiency, and 58.7% 25(OH)D deficiency. Mean 25(OH)D was
19.08 ± 8.44 ng/mL. At the enrollment time (𝑇
0
), no difference was found between Arms A and B with respect to distribution and
25(OH)D levels. At end time (𝑇
1
) 26.0% (29.7% in Arm A versus 20.6% in Arm B) showed sufficiency, 38.4% (42.0% versus 34.4%)
insufficiency, and 35.6% (28.3% versus 45.0%) 25(OH)D deficiency. Mean 25(OH)D level was 23.71 ± 6.83 ng/mL. Conclusions.
Neither changes of lifestyle nor 400 I.U. cholecalciferol supplementation alone appears to be sufficient to restore adequate 25(OH)D
levels.
1. Introduction
Vitamin D status is highly variable among European coun-
tries, largely due to variations in exposure to sunshine, dietary
intake of vitaminD, and the use of supplements [1, 2]. Vitamin
D can be synthesized endogenously, and factors affecting its
cutaneous synthesis include age, season, latitude, time of day,
skin pigmentation, amount of skin exposed, and the use of
sunscreen [2].
Vitamin D status is normally defined according to the
serum concentration of 25-hydroxyvitamin D [25(OH)D]
[3]. Usually, vitaminDdeficiency is defined as having a serum
25(OH)D concentration lower than 50 nmol/L (20 ng/mL)
[3]. Nevertheless, an evaluation of satisfactory levels of
vitamin D in healthy children has not yet been reported by
adequate studies [3–5].
Based on the current literature, the prevalence of
25(OH)D deficiency varies from 2 to 30% in adults [2, 6].
However, in a small-scale Italian study, more than 80% of
children had insufficient or deficient levels of 25(OH)D [7].
Two larger studies providing transversal data have confirmed
that 25(OH)D deficiencies are very common among Italian
children [8–10].
An adequate 25(OH)D status is very important because
25(OH)D deficiency is a risk factor for several chronic
diseases in addition to having classic deleterious effects on
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bone. Vitamin D deficiency can cause secondary hyper-
parathyroidism, which may lead to high bone turnover and
bone loss and ultimately increase the risk of fractures [2–
5]. Emerging evidence suggests that vitamin D also plays
an important role in immune system regulation. Vitamin D
receptors are found on several immune cells, and vitamin
D metabolites appear to modulate T-cell proliferation and
dendritic cell function [11, 12]. Vitamin D deficiency may
also be a risk factor for the development of autoimmune and
other chronic diseases [3, 11, 13, 14], loss of muscle mass,
and muscle weakness [15]. Finally, a number of studies have
also suggested that vitamin D may confer protection against
diabetes mellitus Type 1, hypertension, multiple sclerosis,
and cancer [16]. Thus, vitamin D insufficiency may have
important health consequences not only because of the vita-
min’s role in the maintenance of normal bone mass turnover
but also because of its role as an immunoregulatory agent.
The serum 25(OH)D level is the most commonly measured
indicator of vitamin D status because it reflects dietary intake
from vitamins D2 and D3 together with cutaneous synthesis
of vitamin D3 [17].
Although data are not available regarding the required
vitamin D intake in children, a clinical report from the
American Academy of Pediatrics (AAP) recommended a
daily intake of 400 I.U./day of vitamin D for all infants,
children, and adolescents [18], in contrast with a previous
recommendation of 200 I.U. (5𝜇g)/day [19].
To date, few studies have assessed vitaminD status among
Italian children [7–10], and, to our knowledge, there have
been no longitudinal studies.The available data indicate that,
due to lifestyle changes, the main source of vitamin D, via
synthesis in the skin from cholesterol after exposure to UV-B
light, has been significantly reduced due to the large amount
of time spent indoors [18, 19].
Thus, the purpose of this study was to assess serum
25(OH)D levels in a large cohort of children and adolescents
living in the Italian province of Florence in the Tuscany
region of Italy (latitude 44∘N) and to identify risk factors
for vitamin D deficiency in different age groups. This study
also aimed to evaluate whether a normal 25(OH)D value
can be restored in 25(OH)D-deficient patients with a daily
supplement of 400 I.U. of cholecalciferol or by improving the
factors influencing 25(OH)D status.
2. Patients and Methods
We consecutively evaluated 679 Caucasian children and
adolescents (326 males and 353 females, aged 2.1–17.9) from
Mugello, an area of Tuscany, and Florence (central Italy),
Italy. All of the subjects were selected by random cluster
sampling of the subjects who were seen at the Pediatric Unit
of Mugello’s Hospital of Borgo San Lorenzo or the Endocrine
Paediatric Unit of the Anna Meyer Children’s University
Hospital between September 2010 and December 2013 for
routine control visits. The Hospital Ethics Committees of
Anna Meyer Children’s University Hospital and Mugello’s
Hospital approved the study, which was conducted in accor-
dance with the Declaration of Helsinki guidelines. Written
informed consent was obtained from the parents/guardians
of all of the subjects.
2.1. Study Design. The present study aimed first to assess
cross-sectionally the serum 25(OH)D levels in a very large
cohort of Italian children and adolescents and to identify risk
factors for vitamin D deficiency in these subjects.
For the cross-sectional evaluation, the inclusion criteria
were as follows: patients older than 2 and younger than 18.
The exclusion criteria were as follows: a recent history of
travelling to warmer, sunnier areas prior the study, use of
calcium or vitamin D supplements or any drugs affecting
calcium or vitaminDmetabolismwithin the past six months,
or a positive history of primary hyperparathyroidism or other
skeletal diseases, malabsorptive disorders, or neurological or
renal diseases.
Based on the protocol, this study also included a 12-
month (𝑇
0
−𝑇
1
) controlled longitudinal study comparing the
abilities of vitamin D supplementation and the improvement
of factors influencing 25(OH)D status to ameliorate 25(OH)D
deficiencies.
The patients found to have a 25(OH)D deficiency during
the cross-sectional evaluation were recruited for the longitu-
dinal study (Figure 1). Of the 679 Caucasian subjects initially
included in the cross-sectional evaluation, 398 children and
adolescents (186 males and 212 females, aged 3.1 to 18.9)
having 25(OH)D levels below 20 ng/mL were enrolled in
the interventional study (Figure 1). The mean time elapsed
between the first (𝑇
0
) and the second (𝑇
1
) determinations was
12.1 months (range: 11.8–12.3 months).
These patients were randomly divided into two groups.
Randomization was performed using a computer-generated
random number table with 1.3 : 1 randomization within strata
defined by gender and age.
The patients in the first group, Arm A, were treated
with cholecalciferol 400 I.U. (10 𝜇g)/daily. Of these subjects
(225 subjects, 105 males and 120 females), 12 declined the
consent to participate in the study, and 8 dropped out due to
noncompliance, lack of follow-up, and so forth. In all, 205 of
these individuals (101 males and 104 females) completed the
interventional study and constituted the subjects of Arm A.
The patients in the second group, Arm B, did not receive
cholecalciferol supplements, but they were instructed to
improve variables influencing 25(OH)D levels, including diet,
milk intake, hours spent outdoors, sun exposure, and use of
sunscreen. Of these subjects (173 subjects: 81 males and 92
females), 8 declined the consent to participate in the study,
and 5 dropped out due to noncompliance or lack of follow-
up. The remaining 160 individuals (71 males and 89 females)
completed the interventional study and were the subjects of
Arm B.
2.2. Sample Size Calculation. The number of subjects
required to compare the abilities of the two treatment
arms to attain serum 25(OH)D concentrations of at least
30 ng/mL and to detect a change of at least 1.5 nmol/L in
serum 25(OH)D levels between groups was calculated with
a significance level of 5% and a power of 90%. The aim was
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Figure 1: Summary of patient flow diagram. Individuals with 25(OH)D deficiency. Patients in the Arm A group received 400 I.U. of vitamin
D3 daily during the study, whereas patients in the Arm B group worked to improve factors that influence 25(OH)D status but did not receive
vitamin D3 supplements.
to include at least a 1.3 : 1 ratio due to a higher withdrawal
expected in Arm A.
2.3. Study Protocol. During the cross-sectional evaluation
and the interventional study (𝑇
0
and 𝑇
1
), the clinical and
demographic data were collected from the subjects, including
height, weight, body mass index (BMI), pubertal stage, time
dedicated to outdoor physical activity, sunlight exposure,
and use of sunscreen. Furthermore, nutrient diaries were
recorded for each subject based on their medical charts
and standardized interviews. For both the cross-sectional
and interventional (𝑇
0
and 𝑇
1
) studies, the subjects were
also divided into two age groups: children (2–12 years) and
adolescents (older than 12 years).
During the cross-sectional evaluation, the dietary intakes
of calcium and vitamin D were assessed through a stan-
dardized interview with the parents, recording birth weight,
type of feeding during the first year (breast, formula milk,
or mixed), the mother’s use of vitamin supplements during
pregnancy, and the child’s use of vitamin D supplements [4,
5]. Depending on the age of the child, the parent or guardian
and the child were also interviewed about the frequency
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of consumption (daily, weekly, and monthly) of each food
item with the use of food models, portion booklets, or
serving containers to assist in estimating serving size. Nutri-
ent analyses were obtained from the Food Composition
Database for Epidemiological Studies in Italy (Banca Dati
di Composizione degli Alimenti per Studi Epidemiologici in
Italia—BDA). A daily intake of more than 200mL per day of
cow’s milk (median content of vitamin D was 40 I.U./L) was
considered adequate [4, 5, 20].
During the same interview, we recorded the hours/week
of outdoor physical activity (consequently subdividing our
study group into low level outdoor physical activity (≤2
hours/day) and high level (>2 hours/day)) and categorized
the activity using a physical activity questioner, as previously
described [20]. Outdoor exposure was quantified both from
questions regarding each child’s average number of daily
outdoor hours during each season and from a prospective
daily-time-activity diary completed by caregivers during the
study.
During these interviews, the amount of sun exposure was
also calculated and evaluated in terms of the number of days
of significant exposure to sunlight before the cross-sectional
evaluation and during the period of the study or for the inter-
ventional study, the summer previous to study enrolment. At
our latitude (44∘N), cutaneous synthesis of vitamin D takes
place only during the summer months (May–September)
[4, 5, 21]. We defined significant exposure to sunlight as the
exposure of arms and legs for 15 minutes between 10 a.m. and
3 p.m. without the application of sunscreen [22], identifying
the following three categories: poor (<15 days), moderate (15–
30 days), and good (≥30 days) sun exposure. Sunscreen use
was also evaluated and defined as regular (use of a sunscreen
with a sun protection factor (SPF) ≥ 15 applied at least 30
minutes before sun exposure and subsequently every 2 hours)
or irregular [23].
During the study, all of the subjects underwent laboratory
tests tomeasure their plasma 25(OH)D levels as well as serum
calcium, phosphate, bone-specific alkaline phosphatase (B-
ALP), and parathyroid hormone (PTH) levels.
2.4. Vitamin D Status. The serum 25(OH)D levels were
stratified according to the following brackets: ≤10, 11–20,
21–30, and >30 ng/mL and defined as severe deficiency,
deficiency, insufficiency, and sufficiency, respectively, accord-
ing to previously established guidelines for bone health (in
the absence of a consensus regarding appropriate levels for
endocrine and extraendocrine health) [3–5].
To evaluate seasonal variations, we divided the year into
four seasons. However, although solar winter is typically
defined as the period from November to February, to create
larger,more significant statistical groups,we definedwinter as
the period from November to May and summer as that from
June to October because human insolation to UVB radiation
is negligible between November and April [21].
2.5. Vitamin D Intervention (𝑇
0
and 𝑇
1
). All of the subjects
of Arm A were treated with 400 I.U. (10 𝜇g) of cholecal-
ciferol administered orally once daily. The cholecalciferol
supplement was purchased from Abiogen Pharma S.p.A.
(Pisa, Italy), and the drops contained 250 I.U. (6.25 𝜇g) of
cholecalciferol. The dosage was based on the recommenda-
tion of the American Academy of Pediatrics for all infants,
children, and adolescents [18, 19].
For Arm A, written instructions were provided at the
onset of the study, and compliance was evaluated by a
written questionnaire completed by the parents. Compliance
was further verified by e-mails and/or telephone interviews
performed by a study nurse and by the bottle count of
cholecalciferol performed at the end of the study period.
2.6. Implementation of the Variables Influencing 25(OH)D
Levels (𝑇
0
and 𝑇
1
). For Arm B, after evaluating the ques-
tionnaires about calcium and vitamin D dietary intake,
outdoor physical activity levels, sun exposure, and the use of
sunscreen, the parents and children were informed of how
to safely increase vitamin D levels; this information provided
them with new knowledge and had the potential to change
their attitudes and behaviors.
To eliminate differences in knowledge, at 𝑇
0
, all of the
Arm B families participating in the study received written
and oral information about the importance of vitamin D in
the health of children and adults and the amount of vitamin
D required for good health (Dietary Reference Intake or
DRI). To optimize the consumption of nutrients naturally
rich in vitamin D, such as fish, fatty fish, eggs, milk, and dairy
products, the parents received information about the major
dietary sources of vitamin D. This information was provided
using the Food Composition Database for Epidemiological
Studies in Italy (Banca Dati di Composizione degli Alimenti
per Studi Epidemiologici in Italia - BDA).
The equal importance of a certain amount of sun expo-
sure gained through outdoor activities was also explained.
For Arm B, written instructions were provided at the
onset of the study and compliance was evaluated by a
written questionnaire completed by the parents. Compliance
was further verified by e-mails and/or telephone interviews
performed by a study nurse.
2.7. Measurements. Each subject’s weight was measured with
electric scales to the nearest 0.1 kg, and the height was
measured with a stadiometer. The body mass index (BMI)
was calculated using the following formula: BMI = weight
(kg)/height (m)2. Tanner’s pubertal stage was determined at
baseline and at each visit. The age-related reference values
for height, bone age, and BMI obtained from large sample
numbers of Italian children and currently used in Italy
were used in the study [24]. As described previously [24],
height and BMI were normalized for chronological age by
conversion to standard deviation scores (SDS), which were
calculated according to the following formula:
Patient value − mean of age-related reference value/
standard deviation of the age-related reference value
[25].
The pubertal staging was performed according to the cri-
teria of Tanner and Whitehouse [27], using an orchidometer
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for the boys. Blood samples were obtained from each study
participant after an overnight fast.The plasma concentrations
of calcium, phosphate, andB-ALPwere determined following
routine biochemical laboratory protocols. Serum 25(OH)D
and PTH levels were determined by chemiluminescence
enzyme-labeled immunometric assays using an IMMULITE
2000 Systems analyzer (Siemens, Gwynedd, UK). The intra-
and interassays CVs were < 5% and <8% and <8% and <10%,
respectively. All samples were measured in one laboratory
that takes part in and meets the performance targets for the
vitamin D external quality assessment scheme (DEQAS).
2.8. Statistical Analyses. The statistical analyses were per-
formed using SPSSX software (SPSSX Inc, Chicago, IL,
USA). The characteristics of the study population were
described through frequency distributions for categorical
variables and through means and standard deviations (SDs),
medians, and ranges for continuous variables, depending on
whether the data were normally distributed. The differences
between patient groups and controls were assessed using
Student’s 𝑡-test or the Mann-Whitney 𝑈 test, depending on
the distribution of the analyzed variable. The chi-square
test and Fisher’s exact test were used as appropriate to
examine associations between dichotomous variables. Inter-
group comparisons for parameters were conducted using
analysis of variance (ANOVA) or repeated-measures analysis
of covariance (ANCOVA), as appropriate.
Spearman’s and/or Pearson’s correlation tests were used
to determine the correlation coefficients. A multiple stepwise
regression was performed to investigate factors associated
with insufficient vitamin D status after adjusting for potential
confounders. 𝑃 values < 0.05 were considered to be statisti-
cally significant.
3. Results
3.1. Cross-Sectional Evaluation. The main cross-sectional
results are shown in Table 1. Among the 679 subjects, 482
(71.0%) were found to have a normal weight, 168 (24.7%)
were overweight, and 29 (4.3%) subjects were obese. Divided
by sex, 241 of 353 females (68.3%) had a normal weight, 91
(25.8%) were overweight, and 21 (5.9%) were obese, whereas
238 of 326 males (73.0%) had a normal weight, 77 (23.6%)
were overweight, and 11 (3.4%) were obese.
Of the 679 subjects, 453 (66.7%) were prepubertal,
whereas 226 (33.3%) were pubertal. Divided by sex, 237 of
the 353 females (67.1%) were prepubertal and 116 (32.9%)
were pubertal, whereas 217 of the 326 males (66.5%) were
prepubertal and 109 (33.5%) were pubertal.
With respect to 25(OH)D levels, 77 of 679 (11.3%) subjects
had sufficient levels, 204 (30.0%) had insufficient levels, 259
(38.2%) showed deficient levels, and 139 (20.5%) had a severe
deficiency.
Among all the patients, the mean level of 25(OH)D was
19.08 ± 8.44 ng/mL. Among those with sufficient 25(OH)D
levels, the mean concentration was 33.91 ± 3.51 ng/mL. In
contrast, the mean concentration was 24.58 ± 4.78 ng/mL for
those with insufficient levels, 15.16 ± 2.71 ng/mL for those
Table 1: Main data of the cross-sectional evaluation of Italian
children and adolescents.
Number of subjects (female :male) 679 (353 : 326)
Age, yrs. (median, range) 8.7 (2.1–17.9)
Height (SDS) −0.1 ± 1.5
BMI (SDS) 0.5 ± 1.1
Prepubertal/pubertal ratio 4532 : 226
Serum 25(OH)D status
sufficiency (%) 11.3
insufficiency (%) 30.0
deficiency (%) 38.2
severe deficiency (%) 20.5
Serum 25(OH)D level (ng/mL) 19.08 ± 8.44
children 20.26 ± 8.43
adolescents 11.74 ± 5.78
normal weight 25.66 ± 7.32
overweight 17.13 ± 7.87
obese 12.02 ± 5.67
Dietary intake of vitamin D, IU/day 179.3 ± 43.9
Serum 25(OH)D (ng/mL)
≤2 hrs/day in outdoor activity 14.04 ± 7.49
>2 hrs/day in outdoor activity 23.76 ± 7.58
normal cow’s milk consumption/day 24.41 ± 7.82
reduced cow’s milk consumption/day 17.60 ± 8.74
Parathyroid hormone (pg/mL) 51.13 ± 36.46
with deficient levels, and 7.56 ± 1.64 ng/mL for those with a
very deficient level.
Subdividing the group into children and adolescents, the
children presented with a mean 25(OH)D level of 20.26 ±
8.43 ng/mL, whereas the mean level in adolescents was
11.74 ± 5.78 ng/mL (𝑃 < 0.0005).
Finally, subdividing the group according to BMI, we
found that subjects with a normal weight had significantly
higher 25(OH)D levels (25.66±7.32 ng/mL) than overweight
subjects (17.13 ± 7.87 ng/mL, 𝑃 < 0.0005), obese subjects
(12.02 ± 5.67 ng/mL, 𝑃 < 0.0005), or obese and overweight
subjects combined (15.17 ± 7.34 ng/mL, 𝑃 < 0.0005).
There was a marked seasonal effect on 25(OH)D levels.
In fact, we found that the Italian children in our study had
deficient mean 25(OH)D levels in spring (15.0±6.43 ng/mL).
Although the levels were significantly higher in summer
(25.72±8.60 ng/mL,𝑃 < 0.005) and autumn (23.25±6.58,𝑃 <
0.005 versus spring values; 𝑃 = NS versus summer values),
they were still not sufficient. In winter, the 25(OH) D levels
were also significantly lower than those observed in summer
and fall (15.57 ± 9.17 ng/mL, 𝑃 < 0.005 versus summer
and autumn values) and similar to the levels observed in
spring (𝑃 = NS versus spring value) (Figure 2). If the year
is divided into only two periods (winter as November–May
and summer as June–October), the mean 25(OH)D level was
23.76 ± 7.58 ng/mL in summer and 15.96 ± 8.65 ng/mL in
winter (𝑃 < 0.0005).
Evaluating the effect of hours spent outdoors on 25(OH)D
levels, we showed a significant difference between the group
spending ≤ 2 hours/day in outdoor physical activity (14.04 ±
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7.49 ng/mL) and the group spending > 2 hours/day in
outdoor physical activity (23.76 ± 7.58, 𝑃 < 0.005).
Themean intake of vitaminDwas 179.3±43.9 I.U. per day.
There was no significant difference in the vitamin D intake
between females and males, children and adolescents, or
normal weight, overweight, and obese subjects. However, the
children with appropriate daily intake of cow’s milk showed
significantly higher 25(OH)D levels (24.41±7.82 ng/mL) than
the children who consumed no or only small quantities of
cow’s milk per day (17.60 ± 8.74 ng/mL, 𝑃 < 0.005).
The subjects with low sun exposure showed significantly
reduced 25(OH)D levels (13.47 ± 7.54 ng/mL) than the
subjects with moderate (17.99 ± 8.87 ng/mL; 𝑃 < 0.0001)
and good (25.23 ± 9.88 ng/mL; 𝑃 < 0.0001) sun exposure.
Finally, the subjects who regularly used sunscreen exhibited
significantly lower 25(OH)D levels (15.44 ± 7.65 ng/mL)
than subjects who did not use sunscreen regularly (24.65 ±
9.99 ng/mL; 𝑃 < 0.0001).
Evaluating all of the subjects, we found that 108 of
679 patients (15.9%; 51 males, 57 females) had PTH levels
above the normal range; the mean PTH level was 51.13 ±
36.46 pg/mL. Of the 679 patients, 172 (25.3%; 90 males, 82
females) had high B-ALP levels; the mean B-ALP level was
129.3 ± 36.7U/L.
Evaluating the correlations between 25(OH)D levels and
age, sex, BMI, cow milk consumption (mL/day), outdoor
physical activity (hours/week), use of sunscreen, PTH, cal-
cium, phosphorus, B-ALP, birth weight, type of feeding
during the first year of life, mother’s use of vitamin supple-
mentation during pregnancy, child’s past use of vitamin D
supplementation, and daily intake of cowmilk, we found that
25(OH)D levels correlated with age (𝑟 = −0.56, 𝑃 < 0.0001),
BMI (𝑟 = −0.67, 𝑃 < 0.0001), cow’s milk consumption
(𝑟 = 0.53,𝑃 < 0.005), hours/week of outdoor physical activity
(𝑟 = 0.76, 𝑃 < 0.0001), sunscreen use (𝑟 = −0.63, 𝑃 < 0.005),
sun exposure (𝑟 = 0.69, 𝑃 < 0.0001), PTH levels (𝑟 = −0.59,
𝑃 < 0.001), calcium levels (𝑟 = 0.39, 𝑃 < 0.005), B-ALP
(𝑟 = −0.47, 𝑃 < 0.005), maternal feeding during the first
year of life (𝑟 = 0.29, 𝑃 < 0.005), and the child’s past use
of vitamin D supplementation (𝑟 = 0.45, 𝑃 < 0.0005) but not
with sex, phosphorus levels, birth weight, or the mother’s use
of vitamin supplementation during pregnancy.
3.2. One Year Interventional Study: Enrollment Time or T
0
.
The main results of the one-year interventional study at 𝑇
0
are shown in Table 2. Of the 378 total subjects included in the
interventional study, 272 (72.0%) were of normal weight, 91
(24.1%) were overweight, and 15 (4.0%) were obese (Table 2).
Similar results were found when the subjects were divided
into Arms A and B. In ArmA, 153/213 (71.8%) were of normal
weight, 51/213 (23.9%) were overweight, and 9/213 (4.2%)
were obese, whereas in ArmB, 119/165 (72.1%) were of normal
weight, 40/165 (24.3%) were overweight, and 6/165 (3.6%)
were obese. We did not find significant differences compared
with the results of the cross-sectional evaluation.
Furthermore, we did not find any significant differences
between Arm A and Arm B with respect to the prepu-
bertal/pubertal ratio (in Arm A, 144/213 subjects (67.6%)
were prepubertal, whereas 69 (32.4%) were pubertal, and
in Arm B, 111/165 (67.3%) were prepubertal, whereas 54
(32.8%) were pubertal). No significant differences between
the interventional study and the cross-sectional evaluation
were found with respect to the prepubertal/pubertal ratio.
At 𝑇
0
, of the 378 subjects, 243 (64.3%) had deficient
25(OH)D levels, and 135 (35.7%) exhibited a severe deficiency.
In Arm A, 139/213 (65.3%) showed 25(OH)D deficient levels,
and 74 (34.7%) had a severe deficiency. In Arm B, 104/165
subjects (63.0%) demonstrated deficient 25(OH)D levels, and
61 (37.0%) had a severe deficiency. No significant difference
was found between Arms A and B with respect to the
distribution of 25(OH)D levels.
Among the total number of patients participating in the
study, the mean level of 25(OH)D at 𝑇
0
was 12.53 ± 4.64.
There was no significant difference in the mean 25(OH)D
levels at 𝑇
0
between Arm A (12.42 ± 4.58 ng/mL) and Arm B
(12.64±4.72 ng/mL).Whenwe subdivided the subjects of the
two arms into children and adolescents, for children, mean
25(OH)D levels of 14.04 ± 4.45 and 14.56 ± 4.22 ng/mL were
found in Arms A and B, respectively. For adolescents, the
mean 25(OH)D levels were significantly reduced compared
with those observed for the children (9.87 ± 4.19 and 9.96 ±
4.65 ng/mL in adolescents in Arms A and B; 𝑃 < 0.0001
resp.).
As seen in the cross-sectional evaluation, when we subdi-
vided the Arms A and B subjects according to BMI, we found
that children and adolescents of normal weight presented
with significantly higher 25(OH)D levels (Arm A: 14.52 ±
4.21 ng/mL; Arm B: 14.34±4.14 ng/mL) than the overweight
(Arm A: 11.01 ± 4.39 ng/mL; Arm B: 11.38 ± 4.23 ng/mL;
𝑃 < 0.0001 versus Arm A and Arm B normal weights) and
obese (Arm A: 8.69 ± 3.14 ng/mL; Arm B: 8.54 ± 3.57 ng/mL;
𝑃 < 0.0001 versus Arms A and B normal weight) subjects
in the respective arms. Furthermore, the 25(OH)D levels of
obese subjects in Arms A and B were significantly lower than
the levels observed in the overweight subjects in Arms A and
B, respectively, (𝑃 < 0.05).
As seen in the cross-sectional evaluation, there was a
seasonal effect on 25OHD levels at 𝑇
0
evaluation. In fact, we
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Table 2: Comparison of 25(OH)D determinants in Arms A and B of the interventional study.
Arm A 𝑇
0
Arm A 𝑇
1
Arm B 𝑇
0
Arm B 𝑇
1
Number of subjects (female :male) 213 (200 : 178) 205 (200 : 178) 165 (193 : 172) 160 (193 : 172)
Age, yrs. (median, range) 8.8 (3.1–18.9) 8.8 (3.1–18.9) 9.8 (3.2–19.9) 9.8 (3.2–19.9)
Height (SDS) 0.0 ± 1.5 0.0 ± 1.4 −0.1 ± 1.6 0.0 ± 1.5
BMI (SDS) 0.5 ± 1.1 0.5 ± 1.1 0.5 ± 1.0 0.5 ± 1.0
Prepubertal/pubertal ratio 255 : 123 255 : 123 236 : 129 236 : 129
Serum 25(OH)D status
sufficiency (%) — 29.7∧∧∧ — 20.6∘∘∘∗
insufficiency (%) — 42.0∧∧∧ — 34.4∘∘∘
deficiency (%) 65.3§§§ 21.0∧∧∧ 63.0§§§ 23.1∘∘∘
severe deficiency (%) 34.7§ 7.3∧∧∧ 37.0§§§ 21.9∘∘∘∗∗
Serum 25(OH)D (ng/mL) 12.42 ± 4.58§§§ 25.03 ± 6.84∧∧∧§§§ 12.64 ± 4.72 21.35 ± 7.30∘∘∘∗∗∗
children 14.04 ± 4.45§§§ 24.89 ± 7.54∧∧∧§§§ 14.56 ± 4.22 22.77 ± 7.99∘∘∘∗∗
adolescents 9.87 ± 4.19§§§ 16.00 ± 5.03∧∧∧§§§ 9.96 ± 4.65 14.11 ± 5.99∘∘∘∗
normal weight 14.52 ± 4.21§§§ 25.42 ± 6.67∧∧∧§§§ 14.34 ± 4.14 22.12 ± 6.54∘∘∘∗∗
overweight 11.01 ± 4.39§§§ 21.12 ± 6.23∧∧∧§§§ 11.38 ± 4.23 16.34 ± 6.01∘∗∗
obese 8.69 ± 3.14 14.12 ± 5.43∧§ 8.54 ± 3.57 11.22 ± 6.02
Dietary intake of vitamin D, IU/day 177.3 ± 45.1§§§ 191.4 ± 53.7∧∧§§§ 170.1 ± 47.8 264 ± 53.7∘∘∘∗∗∗
Serum 25(OH)D (ng/mL)
normal milk consumption 13.99 ± 4.53§§§ 20.78 ± 8.33∧∧∧§§§ 13.71 ± 4.11 26.79 ± 8.65∘∘∘∗∗∗
reduced milk consumption 11.18 ± 4.22§§§ 16.59 ± 8.15∧∧∧§§§ 11.06 ± 3.99 17.17 ± 8.18∘∘∘
Serum 25(OH)D (ng/mL)
≤2 hrs outdoor activity/day 10.20 ± 3.78§§§ 13.66 ± 7.78∧∧∧§§ 10.14 ± 3.67 15.29 ± 7.11∘∘∘
2 hrs outdoor activity/day 13.80 ± 5.02§§§ 18.79 ± 8.11∧∧∧§§§ 13.64 ± 4.67 26.49 ± 6.33∘∘∘∗∗∗
Serum 25(OH)D (ng/mL)
low sun exposure 9.82 ± 4.57§§§ 11.88 ± 8.12∧ 9.96 ± 3.89 13.12 ± 8.71∘∘∘
moderate sun exposure 13.23 ± 4.54§§§ 14.66 ± 9.01 13.17 ± 4.11 16.77 ± 6.43∘∘∘∗
good sun exposure 15.34 ± 4.43§§§ 21.65 ± 8.84∧∧∧§§§ 15.45 ± 3.98 24.55 ± 6.11∘∘∘∗∗
Serum 25(OH)D (ng/mL)
regular sunscreen use 10.14 ± 4.65§§§ 17.13 ± 8.01∧∧∧§§§ 10.29 ± 4.58 18.46 ± 7.55∘∘∘
not regular sunscreen use 14.65 ± 3.99§§§ 26.98 ± 8.77∧∧∧§§§ 14.69 ± 4.88 26.03 ± 8.79∘∘∘
Bone-specific alkaline phosphatase (U/L) 131.1 ± 37.3§§§ 112.5 ± 30.6∧∧∧§§§ 128.0 ± 34.9 121.7 ± 32.5∘∗∗∗
Parathyroid hormone (pg/mL) 52.88 ± 33.41 43.01 ± 28.81∧∧∧§§§ 54.54 ± 37.67 49.74 ± 33.71∗
Arm A (𝑇0 or 𝑇1) versus Arm B (𝑇0 or 𝑇1):
∗
𝑃 < 0.05; ∗∗𝑃 < 0.005; ∗∗∗𝑃 < 0.001. Arm A (𝑇0) versus Arm A (𝑇1):
∧
𝑃 < 0.05; ∧∧𝑃 < 0.005; ∧∧∧𝑃 < 0.001. Arm
B (𝑇0) versus Arm B (𝑇1):
∘
𝑃 < 0.05; ∘∘𝑃 < 0.005; ∘∘∘𝑃 < 0.001. Arm A (𝑇0 or 𝑇1) versus Arm A (𝑇0 or 𝑇1) or Arm B (𝑇0 or 𝑇1) versus Arm B (𝑇0 or 𝑇1):
§
𝑃 <
0.05; §§𝑃 < 0.005; §§§𝑃 < 0.001.
found that the 25(OH)D levels were significantly reduced in
spring (11.4 ± 3.76 ng/mL) in 25(OH)D-deficient subjects,
without significant differences between Arm A and Arm B
(Figure 3). However, 25(OH)D levels were higher in summer
(16.37±4.34 ng/mL,𝑃 < 0.0001 versus spring values)whereas
significantly reduced in autumn (14.25 ± 4.07 ng/mL, 𝑃 <
0.005 versus spring values; 𝑃 < 0.005 versus summer values)
and winter (8.48 ± 2.94, 𝑃 < 0.0001 versus other seasons)
(Figure 3), without significant differences between Arm A
and Arm B. If the year is divided into only two periods
(winter as November–May and summer as June–October),
the mean 25(OH)D level was 14.39 ± 4.58 ng/mL in summer
and 9.92 ± 3.97 ng/mL in winter (𝑃 < 0.0001).
With respect to the number of hours spent outdoors, we
found no significant differences between the subjects of Arms
A and B (25% of Arm A subjects and 27% of Arm B subjects
spent no time outdoors, 46% of Arm A subjects and 49%
of Arm B subjects spent < 2 hours per week outdoors, and
29% of Arm A subjects and 24% of Arm B subjects spent
> 2 hours per week outdoors). However, we demonstrated a
significant difference in 25(OH)D levels between the groups
that spent ≤ 2 hours/day in outdoor physical activity (ArmA:
10.20 ± 3.78 ng/mL, Arm B: 10.14 ± 3.67 ng/mL) and those
in the respective arms that spent > 2 hours/day in outdoor
physical activity (Arm A: 13.80±5.02 ng/mL, Arm B: 13.64±
4.67 ng/mL, 𝑃 < 0.0005 for both comparisons).
No significant difference between Arms A and B was
found in the mean intake of vitamin D (Arm A: 177.3 ±
45.1 I.U. per day, Arm B: 170.1 ± 47.8 I.U. per day). As found
in the cross-sectional evaluation, no significant differences
were found in vitamin D intake between females and males,
children and adolescents, or normal weight, overweight,
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Figure 3: Seasonal variation in 25(OH)D levels (ng/mL) in Italian
children and adolescents with 25(OH)D deficiency at baseline (𝑇
0
)
evaluation (versus spring value) in Arm A and Arm B. ∗𝑃 < 0.05;
∗∗
𝑃 < 0.005; ∗∗∗𝑃 < 0.001.
and obese subjects. However, in both arms, we found that
subjects with appropriate intake of cow’s milk had signifi-
cantly higher 25(OH)D levels (Arm A: 13.99 ± 4.53 ng/mL,
Arm B 13.71± 4.11 ng/mL) than the children who consumed
little or no cow’s milk per day (Arm A: 11.18 ± 4.22 ng/mL,
Arm B: 11.06 ± 3.99 ng/mL, 𝑃 < 0.0001 for both compar-
isons).
In both Arms A and B, a low level of sun exposure was
associated with significantly reduced 25(OH)D levels (Arm
A: 9.82 ± 4.57 ng/mL, Arm B: 9.96 ± 3.89 ng/mL) compared
with levels observed in subjects with a moderate (Arm A:
13.23±4.54 ng/mL,ArmB: 13.17±4.11 ng/mL,𝑃 < 0.0005 for
both comparisons) or good (ArmA: 15.34±4.43 ng/mL, Arm
B: 15.45±3.98 ng/mL, 𝑃 < 0.0001 for both comparisons) sun
exposure; no statistical differences were found between Arms
A and B. Regarding the use of sunscreen, we confirmed that
the subjects who regularly used sunscreen had significantly
lower 25(OH)D levels (Arm A: 10.14 ± 4.65 ng/mL, Arm
B: 10.29 ± 4.58 ng/mL) than those with nonregular use of
sunscreen (Arm A: 14.65 ± 3.99 ng/mL, Arm B: 14.69 ±
4.88 ng/mL, 𝑃 < 0.0001 for both comparisons).
We found no significant differences in the frequency of
hyperparathyroidism between Arm A (47/213, 22.1%) and
Arm B (38/165, 23.0%). The mean PTH level was 52.88 ±
33.41 pg/mL in Arm A and 54.54 ± 37.67 pg/mL in Arm B;
these levels were not significantly different. In Arm A, 69/213
subjects (32.4%) had high B-ALP levels, as did 57/165 subjects
(34.5%) inArmB.Themean B-ALP level was 131.1±37.3U/L
in Arm A and 128.0 ± 34.9U/L in Arm B.
Evaluating the correlations among 25(OH)D levels and
age, sex, BMI, cow’s milk consumption (mL/day), outdoor
physical activity (hours/week), use of sunscreen, sun expo-
sure, PTH, calcium, phosphorus, B-ALP, birth weight, type
of feeding during the first year of life, mother’s use of
vitamin supplementation during pregnancy, and child’s past
use of vitamin D supplementation, we found a significant
correlation between 25(OH)D levels and age (𝑟 = −0.53,
𝑃 < 0.0001), BMI (𝑟 = −0.61, 𝑃 < 0.0001), cow’s milk
consumption (𝑟 = 0.58, 𝑃 < 0.005), hours/week of outdoor
physical activity (𝑟 = 0.64, 𝑃 < 0.0001), use of sunscreen
(𝑟 = −0.60, 𝑃 < 0.005), PTH levels (𝑟 = −0.51, 𝑃 < 0.001),
calcium levels (𝑟 = 0.47, 𝑃 < 0.005), B-ALP (𝑟 = −0.53,
𝑃 < 0.001), type of feeding during the first year of life
(𝑟 = 0.38, 𝑃 < 0.005), and the child’s past use of vitamin D
supplementation (𝑟 = 0.49, 𝑃 < 0.0005). No correlation was
found between 25(OH)D levels and sex, phosphorus levels,
birth weight, or the mother’s use of vitamin supplementation
during pregnancy.
3.3. One-Year Interventional Study: End Time or𝑇
1
. Themain
results of the interventional study at 𝑇
1
are shown in Table 2.
At 𝑇
1
, of the 365 patients who completed the study, 287
(78.6%) were of normal weight, 61 (16.7%) were overweight,
and 17 (4.7%) were obese. These findings were not signifi-
cantly different than those observed at 𝑇
0
(72.0% of normal
weight, 24.1% overweight, and 4.0% obese). Moreover, no
difference in the percentages of subjects who were of normal
weight, overweight, and obese at 𝑇
1
and 𝑇
0
was found when
the two arms were considered individually (Arm A: 147/205
(71.7%) were normal weight, 49/205 (23.9%) overweight, and
9/205 (4.4%) were obese, Arm B: 117/160 (73.1%) normal
weight, 39/160 (24.4%) overweight, and 4/160 (2.5%) obese).
At 𝑇
1
, 236/365 (64.7%) subjects were prepubertal,
whereas 129 (35.3%) were pubertal (𝑃 = NS when the
results were compared with those obtained at 𝑇
0
). No sig-
nificant differences in the percentages of prepubertal and
pubertal patients were observed between the arms at 𝑇
1
(Arm A: 137/205 (66.8%) subjects were prepubertal and
68/205 (33.2%) were pubertal; Arm B: 106/160 (66.2%) were
prepubertal and 54/165 (33.8%) were pubertal).
At 𝑇
1
, 95/365 (26.0% versus 0.0% at 𝑇
0
; 𝑃 < 0.0001)
subjects had sufficient 25(OH)D levels, 140 (38.4% versus
0.0% at 𝑇
0
; 𝑃 < 0.0001) had insufficient levels, 80 (21.9%
versus 64.3% at 𝑇
0
; 𝑃 < 0.0001) showed deficient levels, and
50 (13.7% versus 35.7% at 𝑇
0
; 𝑃 < 0.0001) demonstrated
a severe deficiency. At 𝑇
1
, of the 205 subjects in Arm A,
61 (29.7% versus 0.0% at 𝑇
0
; 𝑃 < 0.0001) had sufficient
25(OH)D levels, 86 (42.0% versus 0.0% at 𝑇
0
; 𝑃 < 0.0001)
had insufficient levels, 43 (21.0% versus 65.3% at 𝑇
0
, 𝑃 <
0.0001) showed deficient levels, and 15 (7.3% versus 34.7%
at 𝑇
0
; 𝑃 < 0.0001) had a severe deficiency. In contrast, of
the 160 subjects in Arm B, 33 (20.6% versus 0.0% at 𝑇
0
;
𝑃 < 0.0001) had reached sufficient 25(OH)D levels, 55 (34.4%
versus 0.0% at 𝑇
0
; 𝑃 < 0.0001) had insufficient levels, 37
(23.1% versus 63.0% at 𝑇
0
; 𝑃 < 0.0001) showed deficient
levels, and 35 (21.9% versus 37.0% at 𝑇
0
; 𝑃 < 0.005) had a
severe deficiency. At 𝑇
1
, a significantly greater percentage of
subjects in Arm A had a more sufficient level of 25(OH)D
than those in Arm B (29.7% versus 21.2%; 𝑃 < 0.05), and a
significantly reduced percentage of subjects in Arm A were
considered 25(OH)D-deficient compared to Arm B (28.3%
versus 45%; 𝑃 < 0.005). Only 7.3% of subjects in Arm A
had a severe 25(OH)D deficiency at 𝑇
1
, whereas 21.9% of the
subjects in Arm B were severely deficient (𝑃 < 0.0001).
At 𝑇
1
, the mean level of 25(OH)D of all the patients in
the study was 23.71 ± 6.83 ng/mL, significantly higher than
that observed at 𝑇
0
(12.53 ± 4.64 ng/mL; 𝑃 < 0.0001). More
specifically, at 𝑇
1
, the mean 25(OH)D concentration was
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34.78± 4.04 ng/mL in the subjects with 25(OH)D sufficiency,
24.89 ± 3.56 ng/mL in those who had insufficient 25(OH)D
levels, 19.49 ± 3.77 ng/mL (versus 15.23 ± 3.07 ng/mL at 𝑇
0
,
𝑃 < 0.0001) among those who had deficient 25(OH)D levels,
and 9.23 ± 1.87 ng/mL (versus 7.42 ± 1.78 ng/mL at 𝑇
0
, 𝑃 <
0.0001) among those who had very deficient 25(OH)D levels.
When the subjects were divided in the two arms, those in
Arm A showed significantly higher 25(OH)D levels (25.03 ±
6.84 ng/mL) than those in Arm B (21.35 ± 7.30 ng/mL, 𝑃 <
0.0001). In particular, the 25(OH)D-sufficient subjects in
Arm A had higher mean 25(OH)D levels than the sufficient
subjects in Arm B (35.87 ± 3.86 ng/mL versus 32.58 ±
5.39 ng/mL; 𝑃 < 0.005).
Subdividing the group into children and adolescents,
at 𝑇
1
, children presented a mean 25(OH)D level that was
significantly higher than that found at 𝑇
0
(23.45±7.76 ng/mL
versus 14.34 ± 4.33 ng/mL, 𝑃 < 0.0001). Similar results were
observed when each arm was analyzed separately (Arm A:
24.89±7.54 at𝑇
1
versus 14.04±4.45 at𝑇
0
, ArmB: 22.77±7.99
at 𝑇
1
versus 14.56 ± 4.22 ng/mL at 𝑇
0
, 𝑃 < 0.0001 for both
comparisons). Adolescents also presented with significantly
higher 25(OH)D levels at 𝑇
1
compared with that observed at
𝑇
0
(14.89±4.86 ng/mL versus 9.93±4.38 ng/mL,𝑃 < 0.0001).
Similar results were found when each arm was analyzed
individually (Arm A: 16.00 ± 5.03 at 𝑇
1
versus 9.87 ± 4.19
at 𝑇
0
; Arm B: 14.11 ± 5.99 at 𝑇
1
versus 9.96 ± 4.65 ng/mL at
𝑇
0
, 𝑃 < 0.0001 for both comparisons).
When the subjects were subdivided according to BMI,
at 𝑇
1
, the combined children and adolescents of normal
weight showed significantly higher 25(OH)D levels (23.99 ±
5.66 ng/mL) than overweight subjects (17.13 ± 7.87 ng/mL,
𝑃 < 0.0005) or obese individuals (12.02 ± 5.67 ng/mL, 𝑃 <
0.0001).These differencesweremaintainedwhenArmsAand
B were analyzed separately (Arm A: normal weight subjects
(25.42±6.67 ng/mL), overweight subjects (21.12±6.23 ng/mL;
𝑃 < 0.005), and obese individuals (14.12 ± 5.43 ng/mL; 𝑃 <
0.0001); ArmB: normal weight subjects (22.12±6.54 ng/mL),
overweight subjects (16.34 ± 6.01 ng/mL; 𝑃 < 0.0005), and
obese subjects (11.22 ± 6.02 ng/mL; 𝑃 < 0.0001)).
Despite the efforts to boost 25(OH)D levels in this study,
a seasonal effect on 25(OH)D levels persisted (Figure 4).
Although a significant improvement in 25(OH)D was
observed in most seasons, the 25(OH)D levels in the Italian
subjects remained insufficient in spring (18.90 ± 7.43 at
𝑇
1
versus 15.11 ± 6.55 ng/mL at cross-sectional evaluation,
𝑃 < 0.0001), winter (16.93 ± 9.70 at 𝑇
1
versus 15.41 ±
9.03 ng/mL at cross-sectional evaluation, P = NS), autumn
(26.01±6.54 at𝑇
1
versus 23.25±6.58 ng/mL at cross-sectional
evaluation, 𝑃 < 0.005), and summer (29.27 ± 8.01 at 𝑇
1
versus 25.72 ± 8.60 ng/mL at cross-sectional evaluation, 𝑃 <
0.0001). Similar results were observed when the two arms
were analyzed individually, although the subjects in Arm
A reached normal (sufficient) 25(OH)D values in summer
(32.11 ± 7.23 versus 27.03 ± 8.87 ng/mL in Arm B subjects,
𝑃 < 0.0001).
The subjects in Arm B showed a significant increase
in the number of hours spent outdoors per week (2.59 ±
0.86 at 𝑇
1
versus 1.87 ± 0.65 at 𝑇
0
, 𝑃 < 0.0001). Our
results demonstrated that there were significant differences in
∧∧∧
∧∧∧∧∧∧
∧∧∧
∧∧∧
∧∧∧
∧∧∧
∧∧∧
Vi
ta
m
in
 D
 (n
g/
m
L)
0
10
20
30
40
50
60
Italian children
SummerSpring Autumn Winter
Sufficiency level
∗∗∗
∗∗∗
∗∗∗ ∗∗∗
∗∗∗
9
5
%
CI
∗
∘∘∘
∘∘∘
∘∘
∘∘
Arm A Arm B Arm A Arm B Arm A Arm B Arm A Arm B
Figure 4: Seasonal variation in 25(OH)D levels (ng/mL) in Italian
children and adolescents with 25(OH)D deficiency after cholecal-
ciferol supplementation (Arm A) or implementation of the factors
influencing 25(OH)D status (Arm B) at 𝑇
1
(versus spring value and
versus 𝑇
0
evaluation). ∗𝑃 < 0.05; ∗∗𝑃 < 0.005; ∗∗∗𝑃 < 0.001 versus
spring value. ∧𝑃 < 0.05; ∧∧𝑃 < 0.005; ∧∧∧𝑃 < 0.001 versus 𝑇0
evaluation. ∘𝑃 < 0.05; ∘∘𝑃 < 0.005; ∘∘∘𝑃 < 0.001 (Arm A versus
Arm B values).
25(OH)D levels between the subgroup of Arm B spending ≤
2 hours/day in outdoor physical activity (15.29±7.11 ng/mL)
and those spending> 2 hours/day in outdoor physical activity
(26.49 ± 6.33 ng/mL, 𝑃 < 0.005), with a significant improve-
ment in 25(OH)D levels only achieved in the subgroup
spending> 2 hours/day outdoors. In contrast, inArmA, there
was no significant difference between the 25(OH)D level
of the subgroup spending ≤ 2 hours/day outdoors (13.66 ±
7.78 ng/mL) and that of the subgroup spending > 2 hours/day
outdoors (18.79 ± 8.11 ng/mL).
Furthermore, a significant improvement in the mean
intake of vitaminDwas observed inArmB (264±53.7 I.U per
day at 𝑇
1
versus 170.1 ± 47.8 I.U. per day at 𝑇
0
, 𝑃 < 0.0001),
whereas no improvement in vitamin D intake was observed
in Arm A (191.4± 53.7 I.U. per day at 𝑇
1
). In particular, there
was an increase in the percentage of subjects in Arm B who
consumed a normal amount of cow’s milk over the course
of the study (47.9% versus 37.2%, 𝑃 < 0.05). However, at
𝑇
1
, only Arm B subjects who consumed a normal amount
of cow’s milk per day showed significantly higher 25(OH)D
levels than those who consumed little or no cow’s milk per
day (26.79 ± 8.65 ng/mL versus 17.17 ± 8.18 ng/mL, 𝑃 <
0.0001). In Arm A, at 𝑇
1
, no difference was found in the
25(OH)D levels of those who consumed a normal amount of
cow’s milk and those who consumed little or no cow’s milk
(20.78 ± 8.33 ng/mL versus 16.59 ± 8.15 ng/mL).
In Arm B, we demonstrated an increase in the length
of the sun exposure, with an increase in the percentage of
subjects with moderate sun exposure (48.8% versus 32.7%,
𝑃 < 0.005). There was a significant increase in 25(OH)D
levels compared with those measured at 𝑇
0
for individuals
with low sun exposure (13.12±8.71 versus 9.90±4.41 ng/mL,
𝑃 < 0.0001), moderate exposure (16.77 ± 6.43 versus 13.19 ±
4.32 ng/mL, 𝑃 < 0.0001), and good exposure (24.55 ± 6.11
versus 15.39 ± 4.29 ng/mL, 𝑃 < 0.005). In Arm A, the
25(OH)D levels were significantly reduced with respect to
those detected in the Arm B subjects for each sun exposure
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subgroup (11.88±8.12 ng/mL in thosewith low sun exposure,
14.66 ± 9.01 ng/mL in those with moderate exposure, and
21.65 ± 8.84 in those with good exposure, 𝑃 < 0.0001 for
all comparisons).
At 𝑇
1
, there was no significant difference in the regular
use of sunscreens in the subjects of Arm B. We did confirm
that the subjects who regularly used sunscreen had signifi-
cantly lower 25(OH)D levels than nonregular sunscreen users
(17.86 ± 7.84 ng/mL versus 26.45 ± 8.56 ng/mL, 𝑃 < 0.0001).
There was a significant difference between the 25(OH)D
levels of ArmA regular sunscreen users and nonregular users
(17.13 ± 8.01 ng/mL versus 26.98 ± 8.77 ng/mL, 𝑃 < 0.0001)
and between the 25(OH)D levels of Arm B regular sunscreen
users and nonregular users (18.46±7.55 ng/mL versus 26.03±
8.79, 𝑃 < 0.0001).
When all of the subjects were included, we demonstrated
at𝑇
1
a significant reduction of the percentage of subjects with
hyperparathyroidism (83/365 patients (22.7%), 41 males and
42 females). The mean PTH level was 47.87 ± 31.12 pg/mL
(versus 53.27 ± 34.78 pg/mL at 𝑇
0
; 𝑃 < 0.05). Arm A subjects
showed significantly reduced PTH levels comparedwith Arm
B subjects (43.01 ± 28.81 pg/mL versus 49.74 ± 33.71 pg/mL,
𝑃 < 0.05). After the interventional study, the mean B-ALP
level was 112.5 ± 30.6U/L in Arm A and 121.7 ± 32.5U/L in
Arm B (𝑃 < 0.05).
In our evaluation of potential correlations between
25(OH)D levels and factors potentially affecting 25(OH)D
levels at𝑇
1
(age, sex, BMI, cow’smilk consumption (mL/day),
outdoor physical activity (hours/week), use of sunscreens,
sun exposure, PTH, calcium, phosphorus, birth weight, type
of feeding during the first year of life, mother’s use of vitamin
supplementation during pregnancy, and child’s past use of
vitaminD supplementation), we demonstrated that 25(OH)D
levels correlated with age (𝑟 = −0.57, 𝑃 < 0.005), BMI
(𝑟 = −0.63, 𝑃 < 0.005), cow’s milk consumption (𝑟 = 0.49,
𝑃 < 0.005), outdoor physical activity (𝑟 = 0.66, 𝑃 < 0.0001),
use of sunscreen (𝑟 = −0.49, 𝑃 < 0.005), sun exposure
(𝑟 = 0.53, 𝑃 < 0.005), PTH levels (𝑟 = −0.61, 𝑃 < 0.001),
and calcium levels (𝑟 = 0.44, 𝑃 < 0.005), and B-ALP
(𝑟 = −0.57, 𝑃 < 0.001). No correlation was found between
25(OH)D levels and sex, phosphorus levels, birthweight, type
of feeding during the first year of life, mother’s use of vitamin
supplementation during pregnancy, and child’s past use of
vitamin D supplementation at 𝑇
1
.
4. Discussion
Our study provides data on the 25(OH)D status in a large
sample of children and adolescents in Mugello, an area of
Tuscany, Italy. The extent of the deficiency in most of the
children and adolescents was surprising, confirming a recent
paper of Vierucci et al. [8, 9]. In fact, our data shows a
very high prevalence of vitamin D deficiency (near 56%) in
different age groups. Moreover, if we also include individuals
with an insufficiency, the percentage rises to 88.6%, very
similar to the findings of Vierucci et al. (79.5%) in a different
area of Tuscany [8] and Bellone et al. in a series of northern
Italian children (71.7%) [10].
As expected, our data also demonstrated a strong sea-
sonal influence on vitamin D status, as observed in some
studies performed in countries at northern latitudes and in
different age groups [21, 22], whereas other studies reported
counterintuitive results at different latitudes [23], probably
due to differences in climate. This seasonal effect is probably
related to the reduced exposure of children to sunlight and the
reduced vitamin D production in the skin during the winter
months. In winter, children spend more time indoors, and
when they do go out, the amount of skin exposed to the sun
is less than that during warmer months. As a consequence,
little vitamin D is produced in the skin [10]. Furthermore,
at our latitude, sun exposure is only effective in promoting
vitamin D activation from May through September [21].
Thus, the amount of vitamin D produced and stored October
through April is probably not sufficient to guarantee an
optimal vitaminD status in unsupplemented healthy children
and adolescents, especially if other factors limit summer sun
exposure.
However, the high percentage of vitamin D-deficient and
insufficient children in this paper as well as that reported
by Vierucci et al. and Bellone et al. [8–10] compared with
that reported in previous papers [24–28] may be the result
of changes in the lifestyles of children and adolescents, with
many hours each day spent in indoor activities, such as
school, watching television, or playing games. However, the
use of sunscreen is also an important factor influencing this
very high percentage of children with vitamin D inadequacy.
In our study, the children had higher 25(OH)D levels
than adolescents, most likely due to more outdoors activity,
milk intake, and dietary intake of calcium and vitamin D,
confirming the results of several previous studies [22, 29–31].
Thus, the presence of such a high percentage of subjects
with vitamin D deficiency or insufficiencymay be considered
a “disease” of modern society. In fact, modern lifestyles
and food habits have probably accentuated the predisposing
environmental conditions. The implications of this major
inadequacy in the health of children and adolescents need to
be better defined.
Interestingly, our study demonstrated that neither
lifestyle changes nor supplementation with 400 I.U.
(10 𝜇g)/day of cholecalciferol appears to be individually
sufficient to restore adequate levels of vitamin D in all Italian
children and adolescents. Although many studies have
investigated vitamin D supplementation in healthy adults
[32, 33] as well as adults [34–36], children, and adolescents
[13, 37, 38] with chronic diseases, there are few studies in the
literature which focused on the effect of regular daily vitamin
D supplementation in healthy children and adolescents
[39, 40].
In 323 black and white children who randomly received
0, 400, 1000, 2000, or 4000 IU/d of oral vitamin D3 for 12
weeks during the winter, increases in vitamin D concentra-
tions ranging from −10 nmol/L for the placebo to 76 nmol/L
for 4000 I.U. supplementation were demonstrated [39]. The
authors reported that supplementation with 400 I.U./day
was sufficient to maintain adequate wintertime 25(OH)D
concentrations in healthy black but not white children [39].
However, in another study evaluating 150 healthy children
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with baseline serum 25(OH)D levels < 30 ng/mL, after 4
months of nutritional intervention, the subjects supple-
mented with 400 I.U/d of vitamin D all reached normal
vitaminD levels [40]. In contrast, of the subjectswho received
dietary counseling alone, only one achieved a normal vitamin
D concentration [40]. These results are in contradiction with
our data, in which we identified a considerable group of sub-
jects (almost 15% of those included in the study) with severe
vitaminD deficiency who did not respond to lifestyle changes
or cholecalciferol supplementation. Although we demon-
strated an improvement in the other classes of 25(OH)D
levels (sufficient, insufficient, and deficient levels), over 35%
of the subjects remained 25(OH)D-deficient, and over 73% of
the patients had levels below the sufficiency level after vitamin
D supplementation or implementation of lifestyle changes to
improve vitamin D levels. Specifically, after implementing an
improved diet, higher intake of milk, and increased hours
spent outdoors, although we showed an improvement of
nearly 25% in 25(OH)D levels, 21% of the subjects were
still severely 25(OH)D-deficient. Among the available data of
Italian children and adolescents [4, 5, 8–10], it is interesting
to note that one study reported that 54.8% of 93 subjects had
serum 25(OH)D levels < 20 ng/mL, despite the fact that 33%
of the subjects were receiving vitamin D supplementation at
the time of evaluation [41].
Other studies have demonstrated the importance of
lifestyle changes in improving 25(OH)D levels. In fact, one
study demonstrated that two cups (500mL) of cow’s milk
per day was sufficient to maintain 25(OH)D levels above
75 nmol/L [42]. Our results demonstrated that subjects who
consumed more than 250mL of milk/day had improved
25(OH)D levels and also identified an inverse association
between the intake of cow’s milk and 25(OH)D deficiency,
concordant with other studies, indicating the importance of
a correct diet in reducing a 25(OH)D deficit [43]. A study
of the dietetic habits of our children and adolescents has
demonstrated an increased consumption of alternatives to
milk (such as soy milk and cereals) that provide little vitamin
D and interfere with calcium uptake [44].
The association of a higher risk of 25(OH)D deficit
and limited time spent outdoors reflects another modern
change of the lifestyle of children and adolescents and, as
reported in other studies [22], may indicate the need for
cholecalciferol supplementation to help maintain adequate
levels of vitamin D in Italian children and adolescents. The
promotion of an active outdoor lifestyle may counteract
the vitamin D deficiency epidemic, as suggested by a study
of Saudi children that demonstrated that children who are
physically active have higher levels of vitamin D than those
who are less active, despite having the same amount of
sun exposure [45]. These findings are also confirmed in the
report about 414 girls by Dahifar et al., in which the mean
serum 25(OH)D concentration increased to 14.4± ng/mL
with sunlight exposure [46].
Our data demonstrated that the season of blood with-
drawal is a significant predictor of vitamin D status, with
winter and spring being the seasons associated with lower
median 25(OH)D levels, in the range of deficiency. This
finding is in accordance with other reports [9, 33, 37, 47, 48]
and stresses the importance of the promotion of an active
outdoor lifestyle, especially fromMay to September.
These findings are of particular concern because of both
the well-established and newly identified target effects of
vitamin D (bone accrual and health immunomodulatory
function in decreasing the risk of many chronic illnesses,
including common cancers, autoimmune diseases, infectious
diseases, and cardiovascular disease), stressing the impor-
tance ofmaintaining appropriate 25(OH)D levels [11–16].Our
data seem to confirm and suggest that, individually, lifestyle
changes or vitamin D supplementation is not sufficient to
ensure sufficient 25(OH)D levels. Consequently, a global
intervention or an increase of daily supplementation by
cholecalciferol should be considered.
One limitation of our study was that it is an inter-
ventional open study rather than a randomized controlled
trial. Another limitation was the heterogeneous group of
subjects (obese, overweight, and normal weight children
and adolescents); however, this limitation was also a benefit
because it allowed us to exhaustively evaluate all of the factors
involved in vitamin D status. The large number of children
and adolescents enrolled in our study was a strength.The lack
of vitamin D supplementation at baseline in all subjects was
an additional strength, allowing us to evaluate a large number
of vitamin D status predictors and differentiate between
the effects of vitamin D supplementation and other factors
influencing vitamin D status.
5. Conclusions
In conclusion, deficient or insufficient vitaminD serum levels
were found in most of the Italian children and adolescents
sampled in this study. The presence of inadequate 25(OH)D
levels represents a complex problem that reflects lifestyle
changes, increasingly poor dietary habits, sunscreen use,
and an increase in the obesity rate in the population. Our
findings suggest that neither changes in lifestyles nor or
supplementation with 400 I.U. (10𝜇g)/day of cholecalciferol
appears to be individually sufficient to restore adequate levels
of vitamin D. Thus, daily supplementation with more than
400 I.U. (10 𝜇g) should be considered.
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